摘要
目的:构建含有单纯疱疹病毒1型(HSV-1)UL18基因的原核表达载体。方法:先将UL18基因进行全序列PCR扩增,再将PCR产物克隆进pET-28a(+)质粒,最后将重组质粒转化进入原核表达系统E.coli BL21(DE3)中表达出带有6个组氨酸标签的重组VP23蛋白。结果:UL18基因正确重组进pET-28a(+)质粒,并在E.coli BL21(DE3)中表达。结论:成功构建单纯疱疹病毒1型(HSV-1)UL18基因的重组载体,并在原核表达系统表达出其编码的衣壳蛋白VP23且带有组氨酸标签,为进一步优化VP23在发酵中的最佳表达条件,纯化并大量制备VP23,以及制备VP23的多克隆抗体奠定了基础。
Objective: To construct the prokaryotic expression vectors containing UL18 gene. Methods: UL18 gene was amplified by PCR and cloned into plasmid pET - 28a( + ). Then the recombinant plasmids were trans- formed into prokaryotic expressing system E. coli BL21 ( DE3 ) to express recombinant VP23 attaching with a 5 - His tag. Results: UL18 gene was correctly recombined into plasmid pET -28a( + ) , and expresses its encoding protein VP23 in E. coli BL21 (DE3). Conclusion: The recombinant vectors containing UL18 gene were successfully constructed, and its encoding capsid protein VP23 attaching with a 6 - His tag was also expressed in prokaryotic expressing system, lying a foundation for further optimization of fermentation conditions, purification and preparation of VP23 polyclonal antibody.
出处
《中国卫生检验杂志》
CAS
北大核心
2013年第7期1639-1640,1664,共3页
Chinese Journal of Health Laboratory Technology
基金
国家自然科学基金面上项目(81274170)
十二五国家科技支撑计划
基于南药小分子化合物的抗单纯疱疹病毒药靶发现及药物开发(SQ2011SF12B02099)
省部产学研结合创新科技平台(2010b091000013)
单纯疱疹病毒基因敲除活疫苗研制
国家十二五"863"重大课题"黏膜感染疾病疫苗技术及产品研究"(2012AA02A405)子课题(2012AA02A405-6)